Study variables included a previous history of skin allergy (30.4%), use of calamine lotion (37.7%), topical steroids (10.4%), erythropoietin (60.0%), connective tissue disorder (3.7%), thrice-weekly dialysis (51.9%) and twice-weekly dialysis frequency (48.1%). This evidence concerns the gene EPO and connective tissue disorder.